imatinib
推荐文章
伊马替尼
词汇搭配
短语Imatinib Mesylate 甲磺酸伊马替尼 ; 甲磺酸伊马替尼胶囊 ; 伊马替尼 ; 甲磺酸伊玛替尼
Imatinib Mesilate甲磺酸伊马替尼
imatinib mexylate法检测甲磺酸伊马替尼
Imatinib Mesyla甲磺酸伊马替尼
imatinib sti伊马替尼
Imatinib Capsules甲磺酸伊马替尼
Imatinib Me甲磺酸伊马替尼胶囊
Imatinib Mesylat甲磺酸伊马替尼胶囊
imatinib treatment伊马替尼
更多收起网络短语双语例句
OBJECTIVE Tostudyandimprovethesynthesisof
imatinib
mesylate.目的研究和改进甲磺酸伊马替尼的合成工艺。
www.chemyq.com
Drugslike
imatinib
andsunitinibinhibittheirprimarytargetin ananomolarconcentration.如
imatinib
和sunitinib这样的药物在纳摩尔浓度就抑制它们的主要靶点。Imatinib
isnow thetreatmentof choice for mostnewlydiagnosedpatients.Excellentresponses, in terms ofsymptomcontrolandhaematologicalparameters, are usually obtained.伊马替尼是目前用来治疗新诊断患者的治疗药物，他不仅表现出了良好的治疗反应，以及症状的控制同时获得了许多较好的血液学的参数。
更多双语例句权威例句
Overriding imatinib resistance with a novel ABL kinase inhibitorEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia — NEJM
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results ...
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fr...
Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised c...
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic ...
1. OBJECTIVE To study and improve the synthesis of imatinib mesylate.
目的研究和改进甲磺酸伊马替尼的合成工艺。
www.chemyq.com
2. These data suggest that treatment with imatinib may be a novel therapeutic approach for cryoglobulinemia and MPGN in humans.
这些数据表明，伊马替尼治疗可能是一种治疗人类冷球蛋白血症和MPGN的新方法。
danci.911cha.com
3. "About half of the patients on the study continue to receive imatinib and 40 percent are in complete cytogenetic response, " said Dr.
研究中大约半数的病人继续使用伊马替尼，40%的患者获得完全细胞遗传学缓解。
www.isun.org
4. The anticancer medicine imatinib mesylate was synthesized through steps composed of condensation, reduction and cyclization reaction using 4-methyl-3-nitroaniline as raw material.
以4-甲基-3-硝基苯胺为起始原料，经过缩合、还原、环合等反应制得抗肿瘤药物甲磺酸伊马替尼。
www.dictall.com
5. Objective To detect the ABL point mutations in chronic myeloid leukemia(CML)patients treated with imatinib by denaturing high-performance liquid chromatography(DHPLC).
目的应用变性高效液相色谱（DHPLC）检测伊马替尼治疗后慢性髓性白血病（CML）患者ABL激酶区点突变。
dict.cnki.net
6. Therapeutic concentrations of imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro.
有效治疗浓度的伊马替尼在体外对T细胞增殖和活性有抑制作用。
danci.911cha.com
7. Objective To analyze the frequency and clinical significance of ABL tyrosine kinase point mutations in chronic myeloid leukemia (CML) patients receiving imatinib treatment.
目的探讨伊马替尼治疗慢性粒细胞白血病（CML）患者ABL酪氨酸激酶区点突变的发生情况及临床意义。
www.dictall.com
8. Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
选择最佳的二线酪氨酸激酶抑制剂治疗伊马替尼治疗失败的慢性粒细胞白细胞患者：BCR-ABL突变状态是否真的重要？
www.bloodtime.net
9. Of the 192 patients recruited, 129 completed the study; 58 received intermittent treatment and 26 received continuous imatinib treatment.
在全部192例患者中，129例完成研究，58例接受间断治疗，26例接受持续伊马替尼治疗。
danci.911cha.com
10. However, the price at which imatinib has been offered for sale by Novartis around the world has caused me considerable discomfort.
翻译过来就是，诺华在全球出售伊马替尼的价格搞的我相当的不爽！
blog.sina.com.cn
11. For 5 years, we followed patients with CMLwho received imatinib as initial therapy.
我们对接受伊马替尼作为初始治疗的CML患者进行了5年的随访。
danci.911cha.com
12. Imatinib is currently the most popular therapy for chronic myeloid leukemia (CML).
伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。
www.iciba.com
13. Examples of blood cancer drugs that are taken by mouth are thalidomide, lenalidomide and imatinib mesylate.
治疗血癌的一些口服药物的例子是沙利度胺、来那度胺、伊马替尼。
yiai.org
14. Results Imatinib appeared to be more effective than current standard drug treatments in terms of hematologic and cytogenetic response with better quality of life and fewer side effects.
结果高质量的临床证据表明：在血液学和细胞遗传学缓解率以及生存质量方面，格列卫均优于传统疗法，且副作用相对较少。
dict.cnki.net
15. In this article we reviewed the advances in clinical study of imatinib including its mechanism of resistance, adverse events, life quality study and cost-effective analysis, etc.
本文从耐药机制、不良反应、生活质量考察、药物经济学成本-效用分析等方面综述了其最新临床研究进展。
dict.cnki.net
16. The most GISTs are drug-resistant when be treated with imatinib which is a molecular targeted drug.
应用伊马替尼对包含该突变体的肿瘤进行分子靶向治疗，多数患者表现为药物抵抗。
www.gjbl.net
17. Objective To study the treatment and its possible mechanism of imatinib-induced severe fluid retention in chromic myeloid leukemia(CML).
目的探讨应用伊马替尼（格列卫）治疗慢性粒细胞白血病发生严重水潴留的处理及其可能的发生机制。
www.dictall.com
18. Now, Xiaoyan Jiang and a team of researchers from the British Columbia Cancer Agency in Vancouver and other institutions may have discovered what protects the stem cells from imatinib.
现在来自温哥华英国哥伦比亚肿瘤研究所的江小燕和他的研究者联合其他研究机构可能已经发现了保护干细胞免于伊马替尼 杀伤的途径。
9115428.k46.opensrs.cn
19. Long term regular monitoring of ABL kinase point mutation is necessary during imatinib treatment.
定期监测ABL激酶区点突变有助于及早采取干预治疗，提高疗效。
dict.cnki.net
20. When Zhou and colleagues blocked AHI-1 in cancer cells from imatinib-resistant CML patients, they restored the ability of the drug to kill the cells.
当周和他的同事阻滞了对伊马替尼耐药的白血病患者肿瘤细胞的AHI-1蛋白，他们恢复了该药对干细胞的杀伤作用。
blog.163.com
21. Hematology: Curing CML with imatinib—a dream come true?
用伊马替尼治愈慢粒---快要梦想成真？
blog.sina.com.cn
22. The next step, says Jiang is finding a drug that blocks AHI-1, which could potentially be given in combination with imatinib in the future.
江表示，下一步是找一种阻滞AHI-1的药物，这种药物可能在将来与伊马替尼联用于治疗。
blog.163.com
23. Drugs like imatinib and sunitinib inhibit their primary target in a nanomolar concentration.
如imatinib和sunitinib这样的药物在纳摩尔浓度就抑制它们的主要靶点。
article.yeeyan.org
24. Drugs like imatinib and sunitinib inhibit their primary target in a nanomolar concentration.
如imatinib和sunitinib这样的药物在纳摩尔浓度就抑制它们的主要靶点。
article.yeeyan.org
imatinib
